Xiamen Amoytop Biotech Co., Ltd. (688278.SS) SHH
55.15
-0.85(-1.52%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
55.15
-0.85(-1.52%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
2423
First IPO Date
January 17, 2020
| Name | Title | Pay | Year Born |
| Linzhong Zhang | Deputy General Manager | 0 | 1969 |
| Jiehua Zheng | Deputy General Manager | 0 | 1980 |
| Liyu Shi | Deputy General Manager | 0 | 1980 |
| Weidong Zhou | Deputy General Manager | 0 | 1971 |
| Yiling Yang | Chief Financial Officer, Accounting Supervisor, Deputy GM & Secretary | 0 | 1975 |
| Meihua Yang | Deputy General Manager | 0 | 1972 |
| Li Sun | Chairman & GM | 0 | 1966 |
| Liping Lai | Vice President & Director | 0 | 1971 |
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.